Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Announcement recognises colleagues’ significant and sustained contribution to the University of Oxford.

PSI academics Amanda RojekNick Provine and Emily Adams have been conferred the titles of Associate Professor in recognition of their research standing, teaching and supervision excellence, and good citizenship within the University. 

This distinction comes in acknowledgment of the researchers’ significant and sustained contribution to the achievement of the University’s goals. 

Professor Amanda Rojek is a clinician researcher who works in health emergencies, and in particular, outbreaks of emerging and high-consequences pathogens. At present, she leads a global harmonised trial for treatment of filoviruses(such as Ebola and Marburg disease), and contributes to work across mpox, Nipah virus, Dengue and pathogens with biosecurity risk.    

Amanda said: “I’m really proud of the work we do at the PSI to improve the lives of patients and communities affected by these outbreaks. This title represents the hard work of a large team of people who together ensure we’re doing impactful, meaningful research.”  

Professor Nick Provine is also a Principal Investigator at PSI, where he is undertaking research focused on understanding the innate immune cells and signals that regulate the induction of immunity by vaccination, particularly in the context of viral vector vaccination. In addition to research, he participates in the University's MSc in Integrated Immunology course as a lecturer and course committee member and serves on the Board of Examiners  

Nick said: "This recognition was made possible by the dedication of an excellent team of researchers and educators. It reflects the important role that our research and career development plays in future pandemic preparedness.” 

Professor Emily Adams is a Principal Investigator at PSI, where she works on the development of diagnostics through to implementation focusing on diseases with outbreak potential. She is also Chief Global Health Officer at GADx, a social enterprise company for diagnostics in the UK where she leads the global health portfolio. 

Emily said: “I am delighted to be recognised by the committee and continue the important work on development of diagnostic tests which facilitate fast identification of outbreaks and initiation of treatment and communities requiring vaccination.” 

PSI Director Professor Sir Peter Horby congratulated the three new associate professors. He said: “This recognition is thoroughly deserved by AmandaNick and Emily. All three colleagues have made significant and sustained contributions to the University, demonstrating research standing, excellence in teaching and supervision and good service within the Medical Sciences Division. Alongside PSI colleagues, they are playing a vital role in confronting the challenges of epidemic and pandemic infectious diseases, and I congratulate them and thank them all.”